Fevzi Altuntaş

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

Hematological Malignancy, Medicine, Hematology +6

The outcome of COVID‐19 in patients with hematological malignancy

Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş et al. · Journal of Medical Virology · 2020 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Intensive Care Unit +15

Catheter-related bacteremia due to Kocuria rosea in a patient undergoing peripheral blood stem cell transplantation

Fevzi Altuntaş, Bülent Eser, Kürşat Gündoğan et al. · BMC Infectious Diseases · 2004 · 96 citations · Full text

The Role of Plasma Exchange in HELLP Syndrome

Bülent Eser, Muhammet Güven, Ali Ünal et al. · Clinical and Applied Thrombosis/Hemostasis · 2005 · 86 citations

Thrombosis, Control Group, Autoimmune Disease +15

A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis

Fevzi Altuntaş, Sibel Hacıoğlu, İsmail Koçyiğit et al. · American Journal of Hematology · 2007 · 79 citations

Hematological Malignancy, Clinical Symptoms, Bone Marrow Failure +13